Sonire Therapeutics
Provides High-Intensity Focused Ultrasound treatment for cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD43—64m (Dealroom.co estimates Sep 2022.)
Tokyo Japan (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
JPY530m | Series A | ||
N/A | JPY900m | Late VC | |
Total Funding | AUD17.0m |